6/13
08:14 am
livn
An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 31% Undervalued [Yahoo! Finance]
Low
Report
An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 31% Undervalued [Yahoo! Finance]
6/6
12:15 pm
livn
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
6/6
11:50 am
livn
LivaNova stock falls 11% on VNS Therapy study setback [Seeking Alpha]
Low
Report
LivaNova stock falls 11% on VNS Therapy study setback [Seeking Alpha]
6/6
09:20 am
livn
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients [Yahoo! Finance]
Low
Report
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients [Yahoo! Finance]
6/6
09:00 am
livn
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
High
Report
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
6/3
07:15 pm
livn
Global Pediatric Perfusion Systems Market Size To Exceed USD 1127.3 Million By 2033 | CAGR of 6.90% [Yahoo! Finance]
Low
Report
Global Pediatric Perfusion Systems Market Size To Exceed USD 1127.3 Million By 2033 | CAGR of 6.90% [Yahoo! Finance]
5/23
04:21 pm
livn
What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate? [Yahoo! Finance]
Low
Report
What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate? [Yahoo! Finance]
5/23
09:00 am
livn
LivaNova to Present at the Goldman Sachs Healthcare Conference
Low
Report
LivaNova to Present at the Goldman Sachs Healthcare Conference
5/14
09:43 am
livn
Global Neuromodulation Devices Market Set to Double by 2030: Spinal Cord Stimulation (SCS) Applications Dominate [Yahoo! Finance]
Low
Report
Global Neuromodulation Devices Market Set to Double by 2030: Spinal Cord Stimulation (SCS) Applications Dominate [Yahoo! Finance]
5/13
01:12 pm
livn
Global Chest Drainage Catheters Market to Exhibit Growth at a CAGR of ~5% by 2030 | DelveInsight [Yahoo! Finance]
Low
Report
Global Chest Drainage Catheters Market to Exhibit Growth at a CAGR of ~5% by 2030 | DelveInsight [Yahoo! Finance]
5/3
09:32 am
livn
LivaNova First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
LivaNova First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
5/2
11:55 am
livn
LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/2
08:11 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Robert W. Baird from $58.00 to $66.00. They now have a "neutral" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Robert W. Baird from $58.00 to $66.00. They now have a "neutral" rating on the stock.
5/2
08:10 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Mizuho from $75.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Mizuho from $75.00 to $80.00. They now have a "buy" rating on the stock.
5/1
03:02 pm
livn
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
5/1
08:27 am
livn
LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates [Yahoo! Finance]
Medium
Report
LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates [Yahoo! Finance]
5/1
06:17 am
livn
LivaNova beats top-line and bottom-line estimates; raises FY24 outlook [Seeking Alpha]
High
Report
LivaNova beats top-line and bottom-line estimates; raises FY24 outlook [Seeking Alpha]
5/1
06:08 am
livn
LivaNova Reports First-Quarter 2024 Results [Yahoo! Finance]
High
Report
LivaNova Reports First-Quarter 2024 Results [Yahoo! Finance]
5/1
06:00 am
livn
LivaNova Reports First-Quarter 2024 Results
High
Report
LivaNova Reports First-Quarter 2024 Results
4/30
12:29 pm
livn
LivaNova PLC Q1 2024 Earnings Preview [Seeking Alpha]
Low
Report
LivaNova PLC Q1 2024 Earnings Preview [Seeking Alpha]
4/30
09:12 am
livn
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer [Yahoo! Finance]
Low
Report
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer [Yahoo! Finance]
4/30
09:00 am
livn
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
Low
Report
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
4/26
04:48 pm
livn
Livanova says patient data obtained in 2023 cyberattack [Yahoo! Finance]
Low
Report
Livanova says patient data obtained in 2023 cyberattack [Yahoo! Finance]
4/26
08:06 am
livn
LivaNova gives notice of personal patient data compromised by hackers [Yahoo! Finance]
Low
Report
LivaNova gives notice of personal patient data compromised by hackers [Yahoo! Finance]
4/25
04:20 pm
livn
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident [Yahoo! Finance]
Low
Report
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident [Yahoo! Finance]